My size, inc. (MYSZ)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities:
Net loss

-5,429

-5,497

-4,819

-5,030

-2,073

-5,969

-7,278

-6,524

-9,433

-5,404

-3,733

-3,650

-5,839

-4,334

-4,686

-5,576

-2,962

-3,437

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

3

30

28

29

59

31

32

30

31

30

28

27

25

23

20

16

12

8

0

0

0

Reduction in the carrying amount of the right to use asset

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of warrants and derivatives

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in operating lease liabilities

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest of operating lease liabilities

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of warrant, convertible loans and derivative

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Amortization of warrant, convertible loans and Derivative

-

-

-

-

-

-

-

-

-

-

0

-

0

-

0

-

-

-

-

-

-

Interest payment of short-term loan

-

-

-

-

-

-

-

515

515

323

0

0

0

-

-

-

-

-

-

-

-

Interest and revaluation of short-term deposit

-

55

-50

-2,342

-3,933

-113

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest received from short-term deposit

-

16

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of warrant, convertible loans and derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Revaluation of PUT Option

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

Revaluation of investment in marketable securities

-2

195

361

406

250

-123

-187

-142

95

623

472

0

0

-

0

0

-

-

-

-

-

Valuation of warrants and derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accrued interest on loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Valuation of warrant to purchase Common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stock based compensation

662

692

669

634

402

533

637

580

524

332

136

44

66

-23

20

204

252

398

0

0

0

Stock based compensation - liability

-

-

-

-

-

469

1,506

1,569

1,731

1,297

266

0

0

-

0

-

-

-

-

-

-

Change in embedded derivative

-

-

-

-

-

-

-

87

-

-127

-206

0

0

-

0

0

0

-

-

-

-

Decrease in accounts receivables

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other receivables and prepaid expenses

31

83

54

-244

-183

-142

91

13

-26

-16

-131

-31

20

27

106

26

33

-17

0

0

0

Decrease in trade payable

-39

117

223

-65

85

71

-60

101

23

-9

117

-72

-23

87

0

0

0

-

-

-

-

Increase in accounts payable

60

76

29

111

-91

-37

-166

-225

-9

0

0

0

0

-

-

-

-

-

0

0

0

Increase in deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Increase (decrease) in other accounts payable

-

-

-

-

-

-

-

-

-

-

179

-

-

-

133

96

56

46

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-2,883

-

0

-

-2,274

-1,906

-1,699

-1,439

0

0

0

Net cash used in operating activities

-5,655

-5,418

-4,881

-4,272

-3,604

-3,597

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

Cash flows from investing activities:
Proceeds from restricted deposits

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term deposits

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in right-to-use asset

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

99

103

37

46

45

40

32

18

14

16

13

20

26

36

57

56

51

47

0

0

0

Repayment of a loan

-

-

-

-

-

-

-

-

-

-

10

-

-

-

0

0

0

-

-

-

-

Proceeds from realization of guarantees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Proceeds from Issuing shares, warrants and convertible loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from issuance of shares, warrants and convertible loans

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

Net cash provided by (used in) investing activities

-329

1,073

2,343

-46

-45

-1,421

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Proceeds from exercise of warrants and options

-

-

-

-

-

3,945

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares, net of issuance costs

0

-

-

-

-

5,649

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-13

-

0

-

-57

-56

-51

-47

0

0

0

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Repayment of short-term loan

-

-

-

-

-

-

-

805

-

260

0

0

0

-

-

-

-

-

-

-

-

Repayment of short term loan, net of issuance costs

-

-

-

-

-

-554

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares, warrants, short term loan and convertible loan

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

0

-

-

-

-

9,040

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

Effect of exchange rate fluctuations on cash and cash equivalents

164

315

151

133

-310

-664

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash, cash equivalents and restricted cash

-3,860

-3,764

-2,660

-4,378

-3,913

3,358

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of Common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

2,792

-

0

-

844

1,517

1,763

1,763

0

0

0

Effect of exchange rate fluctuations on cash and cash equivalents

-

-

-

-

-

-

-

-605

-

0

-25

0

0

-

1

-2

4

-3

0

0

0

Increase (decrease) in cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-129

-

-

-885

-1,486

-447

17

274

0

0

0

Non cash activities:
Exercise of warrants and stock-based compensation to equity

-

-

-

-

-

4,703

4,763

4,653

4,353

60

0

0

0

-

-

-

-

-

-

-

-

Derivative liability settles for shares issued

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Warrants reclassified to equity as a result of amended exercise price currency

-

-

-

-

-

-

-

-

-

-

-54

-

-

-

0

0

0

-

-

-

-

Warrants reclassified to equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Conversion of loan to equity

-

-

-

-

-

-

-

-

-

-

4,846

-

-

4,846

0

0

0

-

-

-

-

Non cash share base payments

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Warrants reclassified to equity as a result of amended exercise price currency

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0